Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.
Saved in:
| Title: | Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics. |
|---|---|
| Authors: | Hernandez JJ; Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada., Pryszlak M; Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; The Hospital for Sick Children, Toronto, ON, Canada., Smith L; Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; The Hospital for Sick Children, Toronto, ON, Canada., Yanchus C; Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada., Kurji N; Cyclica Inc., Toronto, ON, Canada., Shahani VM; Cyclica Inc., Toronto, ON, Canada., Molinski SV; Cyclica Inc., Toronto, ON, Canada. |
| Source: | Frontiers in oncology [Front Oncol] 2017 Nov 14; Vol. 7, pp. 273. Date of Electronic Publication: 2017 Nov 14 (Print Publication: 2017). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 29184849 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hernandez+JJ%22">Hernandez JJ</searchLink>; Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Pryszlak+M%22">Pryszlak M</searchLink>; Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; The Hospital for Sick Children, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Smith+L%22">Smith L</searchLink>; Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; The Hospital for Sick Children, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Yanchus+C%22">Yanchus C</searchLink>; Department of Molecular Genetics, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Kurji+N%22">Kurji N</searchLink>; Cyclica Inc., Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Shahani+VM%22">Shahani VM</searchLink>; Cyclica Inc., Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Molinski+SV%22">Molinski SV</searchLink>; Cyclica Inc., Toronto, ON, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2017 Nov 14; Vol. 7, pp. 273. <i>Date of Electronic Publication: </i>2017 Nov 14 (<i>Print Publication: </i>2017). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29184849 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2017.00273 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 273 Titles: – TitleFull: Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hernandez JJ – PersonEntity: Name: NameFull: Pryszlak M – PersonEntity: Name: NameFull: Smith L – PersonEntity: Name: NameFull: Yanchus C – PersonEntity: Name: NameFull: Kurji N – PersonEntity: Name: NameFull: Shahani VM – PersonEntity: Name: NameFull: Molinski SV IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 11 Text: 2017 Nov 14 Type: published Y: 2017 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 7 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |